Corvus Pharmaceuticals
CRVS
#6513
Rank
โ‚น75.58 B
Marketcap
โ‚น896.02
Share price
-3.40%
Change (1 day)
16.70%
Change (1 year)

EPS for Corvus Pharmaceuticals (CRVS)

EPS in 2026 (TTM): -โ‚น56.18

According to Corvus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น56.52. In 2025 the company made an earnings per share (EPS) of -โ‚น14.83 an increase over its 2024 EPS that were of -โ‚น89.88.

EPS history for Corvus Pharmaceuticals from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น56.18278.96%
2025-โ‚น14.83-83.51%
2024-โ‚น89.88
2022-โ‚น82.47-16.04%
2021-โ‚น98.22404.76%
2020-โ‚น19.46-86.79%
2019-โ‚น147.33-9.14%
2018-โ‚น162.16-35.66%
2017-โ‚น252.04-60.47%
2016-โ‚น637.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น125.09 121.31%๐Ÿ‡บ๐Ÿ‡ธ USA